NCT04742816View on ClinicalTrials.gov

Renal Effects of Hormones/Biomarkers in Transgender PrEP Recipients

PHASE4CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

September 17, 2020

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
TransgenderRenal FunctionHormone Replacement Therapy
Interventions
DIAGNOSTIC_TEST

IHX-CL measurements

The distribution of measured IHX-CL values and other continuous variables will be assessed to ensure a parametric distribution.

DRUG

Iohexol

Iohexol clearance measurement

Trial Locations (1)

92103

UC San Diego AntiViral Research Center (AVRC), San Diego

All Listed Sponsors
lead

University of California, San Diego

OTHER

NCT04742816 - Renal Effects of Hormones/Biomarkers in Transgender PrEP Recipients | Biotech Hunter | Biotech Hunter